Literature DB >> 9563747

Movement of tuberculosis patients and the failure to complete antituberculosis treatment.

K C Cummings1, J Mohle-Boetani, S E Royce, D P Chin.   

Abstract

The outcomes of tuberculosis (TB) patients who move before completing antituberculosis treatment have not been described. We studied a population-based cohort of 2,576 adult patients reported as having TB in California during 1993, including 147 patients who moved from one local health jurisdiction to another within California. We determined treatment outcomes (completed, defaulted, died, other) for 131 (89%) of these 147 patients. Patients who moved defaulted more often (relative risk [RR] = 5.5, 95% confidence interval [CI] = 4.1 to 7.4) than patients who did not move. Including these patients' treatment outcomes increased the known number of defaulters by 30%, from 141 to 183 persons. Additionally, diagnosis of TB in a state prison emerged as the strongest risk factor for defaulting from treatment. Patients who moved or defaulted were more likely to abuse drugs or alcohol, to be homeless or to be associated with congregate settings such as jails and prisons. On average, patients who defaulted after moving received less than three-quarters of their recommended treatment regimens. These patients may remain infectious or become infectious again. Our findings highlight the importance of ensuring complete treatment for TB patients who move; failure to do so will adversely affect patient health and TB control, especially in many high-risk populations and settings.

Entities:  

Mesh:

Year:  1998        PMID: 9563747     DOI: 10.1164/ajrccm.157.4.9708058

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  17 in total

Review 1.  Tuberculosis: 13. Control of the disease among aboriginal people in Canada.

Authors:  J M FitzGerald; L Wang; R K Elwood
Journal:  CMAJ       Date:  2000-02-08       Impact factor: 8.262

Review 2.  Optimizing tuberculosis control in the inner city.

Authors:  J M FitzGerald
Journal:  CMAJ       Date:  1999-03-23       Impact factor: 8.262

3.  Recent Developments in Epidemiology, Treatment, and Diagnosis of Tuberculosis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-04       Impact factor: 3.725

4.  Lost in time and space: the outcome of patients transferred out from large hospitals.

Authors:  Sven Gudmund Hinderaker; Razia Fatima
Journal:  Public Health Action       Date:  2013-03-21

5.  An unanswered health disparity: tuberculosis among correctional inmates, 1993 through 2003.

Authors:  Jessica R MacNeil; Mark N Lobato; Marisa Moore
Journal:  Am J Public Health       Date:  2005-10       Impact factor: 9.308

6.  A tuberculosis outbreak fueled by cross-border travel and illicit substances: Nevada and Arizona.

Authors:  Kiren Mitruka; Haley Blake; Philip Ricks; Roque Miramontes; Sapna Bamrah; Carla Chee; Laurie Hickstein
Journal:  Public Health Rep       Date:  2014 Jan-Feb       Impact factor: 2.792

7.  Tuberculosis trends in California correctional facilities, 1993-2013.

Authors:  C J McDaniel; A S Chitnis; P M Barry; N Shah
Journal:  Int J Tuberc Lung Dis       Date:  2017-08-01       Impact factor: 2.373

8.  Marked disparity in the epidemiology of tuberculosis among Aboriginal peoples on the Canadian prairies: the challenges and opportunities.

Authors:  Richard Long; Vernon Hoeppner; Pamela Orr; Martha Ainslie; Malcolm King; Sylvia Abonyi; Maria Mayan; Dennis Kunimoto; Deanne Langlois-Klassen; Courtney Heffernan; Angela Lau; Dick Menzies
Journal:  Can Respir J       Date:  2013-05-28       Impact factor: 2.409

9.  Risk factors and timing of default from treatment for non-multidrug-resistant tuberculosis in Moldova.

Authors:  H E Jenkins; A Ciobanu; V Plesca; V Crudu; I Galusca; V Soltan; T Cohen
Journal:  Int J Tuberc Lung Dis       Date:  2013-03       Impact factor: 2.373

10.  Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

Authors:  Payam Nahid; Susan E Dorman; Narges Alipanah; Pennan M Barry; Jan L Brozek; Adithya Cattamanchi; Lelia H Chaisson; Richard E Chaisson; Charles L Daley; Malgosia Grzemska; Julie M Higashi; Christine S Ho; Philip C Hopewell; Salmaan A Keshavjee; Christian Lienhardt; Richard Menzies; Cynthia Merrifield; Masahiro Narita; Rick O'Brien; Charles A Peloquin; Ann Raftery; Jussi Saukkonen; H Simon Schaaf; Giovanni Sotgiu; Jeffrey R Starke; Giovanni Battista Migliori; Andrew Vernon
Journal:  Clin Infect Dis       Date:  2016-08-10       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.